Jonathan M Peacock
CIK 1500241 · President and CEO · last filed 2025-05-12
Jonathan M Peacock is a President and CEO who has filed 39 SEC Form 4 insider transactions across 5 companies since 2010. The most recent filing, for AVTR, was dated May 12, 2025. Across all open-market trades the lifetime net is +$1.0M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $35.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$35.60M
5
39
$1.00M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AVTR | Director | 219,815 | $9.39 | $2.06M | $103.6K | 4 | 2025-05-12 |
| Avantor, Inc. (AVTRpA) Delisted | Director | 176,339 | $90.81 | $16.01M | $0 | 5 | 2022-05-16 |
| Bellerophon Therapeutics, Inc. (BLPH) Delisted | Director | 157,033 | $0.01 | $1.9K | $900.1K | 18 | 2021-04-02 |
| Kite Pharma, Inc. (KITE) Delisted | Director | 70,374 | — | — | $0 | 3 | 2017-06-22 |
| AMGN | EVP & CFO | 94,414 | $355.20 | $33.54M | $0 | 8 | 2013-10-29 |
Recent Filings
39 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-05-12 | AVTR | Grant (A) | +17,100 | $0 | EDGAR |
| 2025-04-29 | AVTR | Buy (P) | +8,091 | $103.6K | EDGAR |
| 2024-05-13 | AVTR | Grant (A) | +8,477 | $0 | EDGAR |
| 2023-05-15 | AVTR | Grant (A) | +9,808 | $0 | EDGAR |
| 2022-05-16 | Avantor, Inc. (AVTRpA) Delisted | Grant (A) | +6,693 | $0 | EDGAR |
| 2022-04-05 | Avantor, Inc. (AVTRpA) Delisted | Grant (A) | +1,215 | $0 | EDGAR |
| 2021-04-02 | Bellerophon Therapeutics, Inc. (BLPH) Delisted | Grant (A) | +15,308 | $0 | EDGAR |
| 2021-03-01 | Avantor, Inc. (AVTRpA) Delisted | Grant (A) | +7,236 | $0 | EDGAR |
| 2020-02-25 | Avantor, Inc. (AVTRpA) Delisted | Grant (A) | +11,319 | $0 | EDGAR |
| 2020-01-27 | Bellerophon Therapeutics, Inc. (BLPH) Delisted | Grant (A) | +350,000 | $0 | EDGAR |